FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2113064865> ?p ?o ?g. }

• W2113064865 endingPage "2932" @default.
• W2113064865 startingPage "2926" @default.
• W2113064865 abstract "ABSTRACT The response to regimens including lopinavir-ritonavir (LPV/r) in patients who have received multiple protease (PR) inhibitors (PI) can be analyzed in terms of human immunodeficiency virus type 1 (HIV-1) genotypic and pharmacokinetic (pK) determinants. We studied these factors and the evolution of HIV-1 resistance in response to LPV/r in a prospective study of patients receiving LPV/r under a temporary authorization in Bordeaux, France. HIV-1 PR and reverse transcriptase sequences were determined at baseline LPV/r for all the patients and at month 3 (M3) and M6 in the absence of response to treatment. pK measurements were determined at M1 and M3. Virological failure (VF) was defined as a plasma viral load ≥400 copies/ml at M3. A multivariate analysis of the predictors of VF, including clinical and biological characteristics and the treatment history of the patients, was performed. The PR gene sequence at M0, including individual mutations or a previously defined LPV mutation score (D. J. Kempf, J. D. Isaacson, M. S. King, S. C. Brun, Y. Xu, K. Real, B. M. Bernstein, A. J. Japour, E. Sun, and R. A. Rode, J. Virol. 75: 7262-7269, 2001), and the individual exposure to LPV were also included covariates. Sixty-eight patients were enrolled. Thirty-four percent had a virological response at M3. An LPV mutation score of >5 mutations, the presence of the PR I54V mutation at baseline, a high number of previous PIs, prior therapy with ritonavir or indinavir, absence of coprescription of efavirenz, and a lower exposure to LPV or lower LPV trough concentrations were independently associated with VF on LPV/r. Additional PI resistance mutations, including primary mutation I50V, could be selected in patients failing on LPV/r. Genotypic and pK parameters should be used to optimize the virological response to LPV/r in PI-experienced patients and to avoid further viral evolution." @default.
• W2113064865 created "2016-06-24" @default.
• W2113064865 creator A5012034145 @default.
• W2113064865 creator A5024278152 @default.
• W2113064865 creator A5032943621 @default.
• W2113064865 creator A5043340550 @default.
• W2113064865 creator A5049440373 @default.
• W2113064865 creator A5052635966 @default.
• W2113064865 creator A5056304668 @default.
• W2113064865 creator A5067472706 @default.
• W2113064865 creator A5078695748 @default.
• W2113064865 creator A5086527016 @default.
• W2113064865 date "2002-09-01" @default.
• W2113064865 modified "2023-10-06" @default.
• W2113064865 title "Human Immunodeficiency Virus Type 1 Genotypic and Pharmacokinetic Determinants of the Virological Response to Lopinavir-Ritonavir-Containing Therapy in Protease Inhibitor-Experienced Patients" @default.
• W2113064865 cites W2008847285 @default.
• W2113064865 cites W2019691224 @default.
• W2113064865 cites W2051269276 @default.
• W2113064865 cites W2079201451 @default.
• W2113064865 cites W2099697190 @default.
• W2113064865 cites W2112857740 @default.
• W2113064865 cites W2133315239 @default.
• W2113064865 cites W2149568397 @default.
• W2113064865 cites W2154669635 @default.
• W2113064865 cites W2318289184 @default.
• W2113064865 cites W2329393410 @default.
• W2113064865 cites W2339219218 @default.
• W2113064865 doi "https://doi.org/10.1128/aac.46.9.2926-2932.2002" @default.
• W2113064865 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/127404" @default.
• W2113064865 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12183249" @default.
• W2113064865 hasPublicationYear "2002" @default.
• W2113064865 type Work @default.
• W2113064865 sameAs 2113064865 @default.
• W2113064865 citedByCount "108" @default.
• W2113064865 countsByYear W21130648652012 @default.
• W2113064865 countsByYear W21130648652013 @default.
• W2113064865 countsByYear W21130648652014 @default.
• W2113064865 countsByYear W21130648652015 @default.
• W2113064865 countsByYear W21130648652016 @default.
• W2113064865 countsByYear W21130648652017 @default.
• W2113064865 countsByYear W21130648652018 @default.
• W2113064865 countsByYear W21130648652019 @default.
• W2113064865 countsByYear W21130648652020 @default.
• W2113064865 countsByYear W21130648652022 @default.
• W2113064865 crossrefType "journal-article" @default.
• W2113064865 hasAuthorship W2113064865A5012034145 @default.
• W2113064865 hasAuthorship W2113064865A5024278152 @default.
• W2113064865 hasAuthorship W2113064865A5032943621 @default.
• W2113064865 hasAuthorship W2113064865A5043340550 @default.
• W2113064865 hasAuthorship W2113064865A5049440373 @default.
• W2113064865 hasAuthorship W2113064865A5052635966 @default.
• W2113064865 hasAuthorship W2113064865A5056304668 @default.
• W2113064865 hasAuthorship W2113064865A5067472706 @default.
• W2113064865 hasAuthorship W2113064865A5078695748 @default.
• W2113064865 hasAuthorship W2113064865A5086527016 @default.
• W2113064865 hasBestOaLocation W21130648651 @default.
• W2113064865 hasConcept C104317684 @default.
• W2113064865 hasConcept C112705442 @default.
• W2113064865 hasConcept C126322002 @default.
• W2113064865 hasConcept C135763542 @default.
• W2113064865 hasConcept C142462285 @default.
• W2113064865 hasConcept C159047783 @default.
• W2113064865 hasConcept C181199279 @default.
• W2113064865 hasConcept C2522874641 @default.
• W2113064865 hasConcept C2776714187 @default.
• W2113064865 hasConcept C2777182164 @default.
• W2113064865 hasConcept C2777210460 @default.
• W2113064865 hasConcept C2777363262 @default.
• W2113064865 hasConcept C2777583353 @default.
• W2113064865 hasConcept C2779298103 @default.
• W2113064865 hasConcept C2781143361 @default.
• W2113064865 hasConcept C2781392899 @default.
• W2113064865 hasConcept C2781432083 @default.
• W2113064865 hasConcept C2993143319 @default.
• W2113064865 hasConcept C54355233 @default.
• W2113064865 hasConcept C55493867 @default.
• W2113064865 hasConcept C71924100 @default.
• W2113064865 hasConcept C86803240 @default.
• W2113064865 hasConcept C90924648 @default.
• W2113064865 hasConceptScore W2113064865C104317684 @default.
• W2113064865 hasConceptScore W2113064865C112705442 @default.
• W2113064865 hasConceptScore W2113064865C126322002 @default.
• W2113064865 hasConceptScore W2113064865C135763542 @default.
• W2113064865 hasConceptScore W2113064865C142462285 @default.
• W2113064865 hasConceptScore W2113064865C159047783 @default.
• W2113064865 hasConceptScore W2113064865C181199279 @default.
• W2113064865 hasConceptScore W2113064865C2522874641 @default.
• W2113064865 hasConceptScore W2113064865C2776714187 @default.
• W2113064865 hasConceptScore W2113064865C2777182164 @default.
• W2113064865 hasConceptScore W2113064865C2777210460 @default.
• W2113064865 hasConceptScore W2113064865C2777363262 @default.
• W2113064865 hasConceptScore W2113064865C2777583353 @default.
• W2113064865 hasConceptScore W2113064865C2779298103 @default.
• W2113064865 hasConceptScore W2113064865C2781143361 @default.
• W2113064865 hasConceptScore W2113064865C2781392899 @default.
• W2113064865 hasConceptScore W2113064865C2781432083 @default.
• W2113064865 hasConceptScore W2113064865C2993143319 @default.
• W2113064865 hasConceptScore W2113064865C54355233 @default.

• next